食品伙伴網(wǎng)訊  2019年6月11日，歐洲食品安全局發(fā)布消息，應(yīng)歐盟委員會的要求，歐盟膳食、營養(yǎng)和過敏癥科學小組（NDA）根據(jù)法規(guī)（EU）2015/2283就2'-巖藻糖乳糖/二巖藻糖乳糖混合物（2‘‐fucosyllactose/difucosyllactose mixture）作為新型食品提供科學意見。

 

　　據(jù)了解，這種新型食品一種粉末狀混合物，主要由兩種寡糖組成，主要用于包括嬰兒配方奶粉、嬰幼兒食品、特殊醫(yī)療食品和食品補充劑等中。經(jīng)過評估，小組得出結(jié)論，在建議的目標人群使用條件下，這種新型食品是安全的。

 

　　部分原文報道如下：

 

　　Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens （NDA） was asked to deliver an opinion on 2’‐fucosyllactose/difucosyllactose （2‘‐FL/DFL） mixture as a novel food （NF） pursuant to Regulation （EU） 2015/2283. The NF is a powdered mixture mainly composed of two oligosaccharides, 2’‐FL and DFL, which are produced together by fermentation with a genetically modified strain of Escherichia coli K12. The information provided on the manufacturing process, composition and specifications of the NF does not raise safety concerns. The applicant intends to add the NF in a variety of foods, including infant and follow‐on formula, foods for infants and young children, foods for special medical purposes and food supplements. The target population is the general population except for food supplements, for which the target population is individuals above 1 year of age. Since the intake of 2‘‐FL and DFL from the NF at the proposed use levels is unlikely to exceed the intake level of naturally occurring 2’‐FL and DFL in breastfed infants per kilogram body weight, the Panel concludes that the NF, a mixture of 2‘‐FL and DFL, is safe under the proposed conditions of use for the proposed target population.

 

　　本文由食品伙伴網(wǎng)食品資訊中心編輯，供網(wǎng)友參考，歡迎轉(zhuǎn)載，轉(zhuǎn)載請注明出處！有任何疑問，請聯(lián)系news@foodmate.net。